4
February
#WorldCancerDay
#WeCanICan

Geraldine, Peru

All stories
603A3408.JPG

Cervical cancer is the leading cause of death for women in Peru, as 4,636 new cases have occurred representing a standardized incidence rate of 32.7 per 100,000 thousand women, so it was estimated that killed 1,715 women according Globocan 2012.

There are barriers to overcoming gender inequity in health, which are unnecessary, avoidable and unfair, especially for women. In Peru, of the total number of cancer types registered by the Ministry of Health (MINSA), cervical cancer occupies 16.5% of the coast, 17.8% of the highlands, and 26.5% of the forest. With the test of VIA (Visual Inspection with Acetic Acid), the woman reduces their waiting times to the result of the same, in this way increases the reliability in the health system, it reduces the fear of the procedure with cultural adaptation and mitigating The language barrier, the cost they had to make, and the geographical gaps in extending VIA to rural areas far removed from a health facility.

As part of my activities as Midwife, I contribute to the prevention of cervical cancer control through visual inspection screening and cryotherapy treatment.

VIA screening uses dilute acetic acid solution (vinager) to 3-5% , which is applied in the  epithelium of the cervix, producing color changes (temporarily appers white) when exposed to vinegar, this being an indicator of abnormal tissue (positive VIA). It is easy to learn, presents low sustaining costs, and the test results are available immediately.

crio3.png

To reach the target audience, it began with the training of 34 trainers 5 regions for the cascade effect at the national level. Manuals and guides used were validated by JHPIEGO and PATH.

These were the results of the activities: 

1,389 trained professionals, 72 training courses, 34 trainers in VIA and cryotherapy treatment by 2014.

8,081 women agreed to VIA screening as a result of the training of trainers by INEN team in 2012-2014. Of which 460 women had a positive test for possible cervical precancerous lesions, 18 women were suspicious for cancer and 7,603 with negative results.

460 women with positive cervical precancerous lesions for diagnosis, of which 361 were immediately treated with cryotherapy and 99 not suitable for cryotherapy were referred for confirmatory diagnosis.

Conclusions:

VIA screening associated with cryotherapy treatment is an alternative to screening instead of conventional cytology; allows women finding a midwife on primary health care centers and offers the possibility of improving the impact of prevention programs in low-resource settings.

To Peruvian women represent an opportunity to access their right to health, thus preventing morbidity and mortality from cervical cancer.